当前位置: X-MOL 学术Stem Cells Transl. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
CORRIGENDUM
STEM CELLS Translational Medicine ( IF 5.4 ) Pub Date : 2021-07-26 , DOI: 10.1002/sct3.12983


STEM CELLS Translational Medicine 2016;5:1644-1655;doi: 10.5966/sctm.2015-0373

Corrigendum to: Induced Pluripotent Stem Cells for Disease Modeling and Evaluation of Therapeutics for Niemann-Pick Disease Type A

Yan Long, Miao Xu, Rong Li, Sheng Dai, Jeanette Beers, Guokai Chen, Ferri Soheilian, Ulrich Baxa, Mengqiao Wang, Juan J. Marugan, Silvia Muro, Zhiyuan Li, Roscoe Brady, Wei Zheng

The authors reported an error in the Results section of this article. In the first paragraph of the first heading, “Generation of iPSC Lines From NPA Patient Fibroblasts and NSC Differentiation”, the first sentence showed the names of the two cell lines switched. The sentence should have read as follows:

Two NPA patient fibroblast lines were reprogrammed to iPSCs, and two iPSC colonies were established for each patient line as HT138C, HT138F from GM16195 and HT139B and HT139E from GM13205 (Fig. 1A; supplemental online Table 1).

The two bolded cell line names were incorrect and are now corrected.

The authors regret the error and apologize for any inconvenience this may have caused.



中文翻译:

勘误表

干细胞转化医学 2016;5:1644-1655;doi:10.5966/sctm.2015-0373

更正:用于 Niemann-Pick 疾病 A 型疾病建模和治疗评估的诱导多能干细胞

延龙、徐淼、李蓉、戴盛、珍妮特·比尔斯、郭凯陈、索黑莲、乌尔里希·巴克萨、王梦乔、Juan J. Marugan、西尔维娅·穆罗、李志远、罗斯科·布雷迪、魏征

作者在本文的结果部分报告了一个错误。在第一个标题的第一段“从 NPA 患者成纤维细胞和 NSC 分化中生成 iPSC 系”中,第一句话显示了切换的两个细胞系的名称。这句话应该是这样写的:

两个 NPA 患者成纤维细胞系被重新编程为 iPSC,并为每个患者系建立了两个 iPSC 集落,分别是来自GM16195 的 HT138C、HT138F 和来自GM13205 的HT139B 和HT139E(图 1A;补充在线表 1)。

两个加粗的细胞系名称不正确,现在已更正。

作者对错误表示遗憾,并对由此可能造成的任何不便表示歉意。

更新日期:2021-08-23
down
wechat
bug